These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2189084)

  • 1. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
    Noseworthy JH; Vandervoort MK; Wong CJ; Ebers GC
    Neurology; 1990 Jun; 40(6):971-5. PubMed ID: 2189084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group.
    Goodkin DE; Cookfair D; Wende K; Bourdette D; Pullicino P; Scherokman B; Whitham R
    Neurology; 1992 Apr; 42(4):859-63. PubMed ID: 1565242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test.
    Bowen J; Gibbons L; Gianas A; Kraft GH
    Mult Scler; 2001 Jun; 7(3):201-6. PubMed ID: 11475445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.
    Bove R; Bevan C; Crabtree E; Zhao C; Gomez R; Garcha P; Morrissey J; Dierkhising J; Green AJ; Hauser SL; Cree BA; Wallin MT; Gelfand JM
    Mult Scler; 2019 Oct; 25(11):1526-1534. PubMed ID: 30141729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observer disagreement in rating neurologic impairment in multiple sclerosis: facts and consequences.
    Verdier-Taillefer MH; Zuber M; Lyon-Caen O; Clanet M; Gout O; Louis C; Alpérovitch A
    Eur Neurol; 1991; 31(2):117-9. PubMed ID: 2044616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
    Lancet; 1991 Feb; 337(8739):441-6. PubMed ID: 1671468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional system scores provide a window into disease activity occurring during a multiple sclerosis treatment trial.
    Scott TF; You X; Foulds P
    Neurol Res; 2011 Jun; 33(5):549-52. PubMed ID: 21669126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Walking function in clinical monitoring of multiple sclerosis by telemedicine.
    Sola-Valls N; Blanco Y; Sepúlveda M; Llufriu S; Martínez-Lapiscina EH; La Puma D; Graus F; Villoslada P; Saiz A
    J Neurol; 2015 Jul; 262(7):1706-13. PubMed ID: 25957639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.
    Cohen YC; Hassin-Baer S; Olmer L; Barishev R; Goldhammer Y; Freedman L; Mozes B
    Mult Scler; 2000 Oct; 6(5):355-61. PubMed ID: 11064447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
    Cho JY; Hong KS; Kim HJ; Kim SH; Min JH; Kim NH; Ahn SW; Park MS; An JY; Kim BJ; Kim W
    Mult Scler; 2014 Aug; 20(9):1217-23. PubMed ID: 24399825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fatigability on Expanded Disability Status Scale components in multiple sclerosis.
    Dujmović I; Demetz S; Millonig A; Deisenhammer F
    Srp Arh Celok Lek; 2016; 144(5-6):262-5. PubMed ID: 29648741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MS Impairment Scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis.
    Ravnborg M; Grønbech-Jensen M; Jønsson A
    Mult Scler; 1997 Feb; 3(1):31-42. PubMed ID: 9160344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychometric properties of clinical rating scales used in multiple sclerosis.
    Sharrack B; Hughes RA; Soudain S; Dunn G
    Brain; 1999 Jan; 122 ( Pt 1)():141-59. PubMed ID: 10050902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
    Kragt JJ; Nielsen IM; van der Linden FA; Uitdehaag BM; Polman CH
    Mult Scler; 2006 Dec; 12(6):782-6. PubMed ID: 17263007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.
    Ravnborg M; Blinkenberg M; Sellebjerg F; Ballegaard M; Larsen SH; Sørensen PS
    Mult Scler; 2005 Feb; 11(1):81-4. PubMed ID: 15732271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time between expanded disability status scale (EDSS) scores.
    Zurawski J; Glanz BI; Chua A; Lokhande H; Rotstein D; Weiner H; Engler D; Chitnis T; Healy BC
    Mult Scler Relat Disord; 2019 May; 30():98-103. PubMed ID: 30763908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.